Back
Heron Therapeutics Stock Price Chart
Sponsored
HRTX
Sponsored
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--here
Sell
32
HRTX
Heron Therapeutics
Last Price:
$1.60
Seasonality Move:
11.9%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
The current trend is relatively stagnant and HRTX is experiencing slight selling pressure.
Heron Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.6 | Sell |
20-day SMA: | 1.52 | Buy |
50-day SMA: | 1.56 | Buy |
200-day SMA: | 2.41 | Sell |
8-day EMA: | 1.59 | Sell |
20-day EMA: | 1.55 | Buy |
50-day EMA: | 1.61 | Sell |
200-day EMA: | 2.06 | Sell |
Heron Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.03 | Buy |
Relative Strength Index (14 RSI): | 52.12 | Buy |
Chaikin Money Flow: | -140520 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.19 - 1.69) | Buy |
Bollinger Bands (100): | (1.45 - 2.09) | Sell |
Heron Therapeutics Technical Analysis
Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
-
Heron Therapeutics share price is 1.58 while HRTX 8-day simple moving average is 1.60, which is a Sell signal.
-
The stock price of HRTX is 1.58 while Heron Therapeutics 20-day SMA is 1.52, which makes it a Buy.
-
Heron Therapeutics 50-day simple moving average is 1.56 while HRTX share price is 1.58, making it a Buy technically.
-
HRTX stock price is 1.58 and Heron Therapeutics 200-day simple moving average is 2.41, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
32
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a SellThe current Heron Therapeutics [HRTX] share price is $1.58. The Score for HRTX is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
240.3M
Price in USD:
1.58
Share Volume:
702.6K
Heron Therapeutics 52-Week Range
52-Week High:
3.93
52-Week Low:
1.04
Sell
32
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?The Heron Therapeutics stock price is 1.58 USD today.
-
Will HRTX stock go up or go down?Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Heron Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
-
Heron Therapeutics share price is 1.58 while HRTX 8-day exponential moving average is 1.59, which is a Sell signal.
-
The stock price of HRTX is 1.58 while Heron Therapeutics 20-day EMA is 1.55, which makes it a Buy.
-
Heron Therapeutics 50-day exponential moving average is 1.61 while HRTX share price is 1.58, making it a Sell technically.
-
HRTX stock price is 1.58 and Heron Therapeutics 200-day simple moving average is 2.06, creating a Sell signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.75 per share, and an increase next year of $0.10 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
-
HRTX Moving Average Covergence Divergence (MACD) indicator is 0.03, suggesting Heron Therapeutics is a Buy
-
Heron Therapeutics Relative Strength Index (RSI) is 52.12, which suggest Heron Therapeutics is overbought
-
The Bollinger Bands (25) for Heron Therapeutics is (1.19 - 1.69), which suggest Heron Therapeutics is a Sell
-
The Bollinger Bands (100) for Heron Therapeutics is (1.45 - 2.09), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.